20/20 Biolabs, Inc. ownership filing: Streeterville Capital LLC reports beneficial ownership of 543,680 shares, representing 9.99% of the company's common stock. The filing cites 5,442,249 shares outstanding as of February 18, 2026 and attributes the position to warrants and Series E convertible preferred rights subject to a contractual 9.99% ownership cap.
The report is filed by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife, who is identified as manager/sole member; voting and dispositive power is reported as sole for 543,680 shares.
Positive
None.
Negative
None.
Insights
Streeterville holds a capped near-10% stake via convertible instruments and warrants.
The filing states Streeterville Capital LLC beneficially owns 543,680 shares, equal to 9.99% of outstanding common stock as of February 18, 2026. The position reflects rights under a Warrant and Series E Convertible Preferred Stock and is limited by a contractual ownership cap of 9.99%.
Ownership is reported as sole voting and dispositive power. Subsequent filings or exchanges may reveal if conversions or warrant exercises are constrained by the 9.99% cap.
Schedule 13G discloses beneficial ownership and the reporting structure between entities and an individual.
The report is filed jointly by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife; Streeterville Management is manager of Streeterville Capital, and Mr. Fife is sole member of the manager. The filing ties the 543,680-share figure to instrument rights and the contractual 9.99% cap.
Filing shows sole voting and dispositive power for the stated shares. No sale or acquisition transaction is disclosed here; this is an ownership disclosure under securities rules.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
20/20 Biolabs, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
90138K101
(CUSIP Number)
02/25/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
90138K101
1
Names of Reporting Persons
Streeterville Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UTAH
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
543,680.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
543,680.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
543,680.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Reporting Person Streeterville Capital, LLC ("Streeterville") has rights, under a Warrant and Series E Convertible Preferred Stock, to own an aggregate number of shares of the Issuer's common stock which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such a cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's common stock beneficially owned by Streetertville as of the date of this filing was 543,680 shares, which is 9.99% of the 5,442,249 shares outstanding on February 18, 2026 (as reported in the Issuer's Form 424B3 filed on that date).
To clarify, the Form line 11 is limited to displaying only the tenth decimal place, but the ownership limitation prescribed in the agreement is 9.99%.
SCHEDULE 13G
CUSIP No.
90138K101
1
Names of Reporting Persons
Streeterville Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UTAH
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
543,680.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
543,680.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
543,680.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Reporting Person Streeterville Management, LLC is the manager of Streeterville. Streeterville has rights, under a Warrant and Series E Convertible Preferred Stock, to own an aggregate number of shares of the Issuer's common stock which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such a cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's common stock beneficially owned by Streetertville as of the date of this filing was 543,680 shares, which is 9.99% of the 5,442,249 shares outstanding on February 18, 2026 (as reported in the Issuer's Form 424B3 filed on that date).
To clarify, the Form line 11 is limited to displaying only the tenth decimal place, but the ownership limitation prescribed in the agreement is 9.99%.
SCHEDULE 13G
CUSIP No.
90138K101
1
Names of Reporting Persons
John M Fife
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
543,680.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
543,680.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
543,680.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: Reporting Person John Fife is the sole member of Streeterville Management, LLC, which is the manager of Streeterville. Streeterville has rights, under a Warrant and Series E Convertible Preferred Stock, to own an aggregate number of shares of the Issuer's common stock which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such a cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's common stock beneficially owned by Streetertville as of the date of this filing was 543,680 shares, which is 9.99% of the 5,442,249 shares outstanding on February 18, 2026 (as reported in the Issuer's Form 424B3 filed on that date).
To clarify, the Form line 11 is limited to displaying only the tenth decimal place, but the ownership limitation prescribed in the agreement is 9.99%.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
20/20 Biolabs, Inc.
(b)
Address of issuer's principal executive offices:
9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Item 2.
(a)
Name of person filing:
This report is filed by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife with respect to the shares of Ordinary Shares of the Issuer that are directly beneficially owned by Streeterville Capital LLC and indirectly beneficially owned by the other reporting and filing persons.
(b)
Address or principal business office or, if none, residence:
300 East Randolph Street, Suite 40.150
Chicago, IL 60601
(c)
Citizenship:
Streeterville Capital LLC is a Utah limited liability company.
Streeterville Management LLC is a Utah limited liability company.
John M. Fife is a United States citizen.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
90138K101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
543,680
(b)
Percent of class:
9.99%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
543,680
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
543,680
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What stake does Streeterville Capital LLC report in 20/20 Biolabs (AIDX)?
Streeterville Capital LLC reports beneficial ownership of 543,680 shares, equal to 9.99% of common stock as of February 18, 2026. The position arises from warrants and Series E convertible preferred rights subject to a contractual cap.
How many shares outstanding does 20/20 Biolabs report in this filing?
The filing cites 5,442,249 shares outstanding as of February 18, 2026, which is the reference used to calculate the 9.99% ownership percentage reported by Streeterville.
Who else is listed on the Schedule 13G besides Streeterville Capital LLC?
The report is filed jointly by Streeterville Management LLC and John M. Fife; Streeterville Management is the manager of Streeterville Capital and Mr. Fife is its sole member, per the filing's disclosures.
Does the filing show any sales or purchases of AIDX stock?
No; this Schedule 13G discloses beneficial ownership only. It reports voting and dispositive power for 543,680 shares but does not describe any open-market purchases or sales in the disclosed text.
Why is the ownership percentage shown as 9.9% on the form?
The filing explains the Form line displays only to the tenth decimal place; the contractual ownership limit is stated as 9.99%, and the filer reports beneficial ownership at that capped level against the 5,442,249 shares outstanding figure.
